Literature DB >> 15307119

Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.

Laura Welch1, Knut Ringen, Eula Bingham, John Dement, Tim Takaro, William McGowan, Anna Chen, Patricia Quinn.   

Abstract

BACKGROUND: To determine whether current and former construction workers are at significant risk for occupational illnesses from work at the Department of Energy's (DOE) nuclear weapons facilities, screening programs were undertaken at the Hanford Nuclear Reservation, Oak Ridge Reservation, and the Savannah River Site.
METHODS: Medical examination for beryllium disease used a medical history and a beryllium blood lymphocyte proliferation test (BeLPT). Stratified and multivariate logistic regression analyses were used to explore the risk of disease by age, race, sex, trade, duration of DOE employment, reported work in buildings where beryllium was used, and time since last DOE site employment.
RESULTS: Of the 3,842 workers included in this study, 34% reported exposure to beryllium. Overall, 2.2% of workers had at least one abnormal BeLPT test, and 1.4% were also abnormal on a second test. Regression analyses demonstrated increased risk of having at least one abnormal BeLPT to be associated with ever working in a site building where beryllium activities had taken place.
CONCLUSIONS: The prevalence of beryllium sensitivity and chronic beryllium disease (CBD) in construction workers is described and the positive predictive value of the BeLPT in a population with less intense exposure to beryllium than other populations that have been screened is discussed. The BeLPT findings and finding of cases of CBD demonstrate that some of these workers had significant exposure, most likely, during maintenance, repair, renovation, or demolition in facilities where beryllium was used.

Entities:  

Mesh:

Year:  2004        PMID: 15307119     DOI: 10.1002/ajim.20059

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  14 in total

Review 1.  Chronic beryllium disease: an updated model interaction between innate and acquired immunity.

Authors:  Richard T Sawyer; Lisa A Maier
Journal:  Biometals       Date:  2010-10-28       Impact factor: 2.949

2.  Beryllium's public relations problem: protecting workers when there is no safe exposure level.

Authors:  David Michaels; Celeste Monforton
Journal:  Public Health Rep       Date:  2008 Jan-Feb       Impact factor: 2.792

3.  Efficacy of a program to prevent beryllium sensitization among new employees at a copper-beryllium alloy processing facility.

Authors:  Carrie A Thomas; Rachel L Bailey; Michael S Kent; David C Deubner; Kathleen Kreiss; Christine R Schuler
Journal:  Public Health Rep       Date:  2009 Jul-Aug       Impact factor: 2.792

4.  Progression from beryllium exposure to chronic beryllium disease: an analytic model.

Authors:  Philip Harber; Siddharth Bansal; John Balmes
Journal:  Environ Health Perspect       Date:  2009-02-27       Impact factor: 9.031

5.  Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility.

Authors:  Mehrdad Arjomandi; James Seward; Michael B Gotway; Stephen Nishimura; George P Fulton; Josef Thundiyil; Talmadge E King; Philip Harber; John R Balmes
Journal:  J Occup Environ Med       Date:  2010-06       Impact factor: 2.162

6.  Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry.

Authors:  Michael V Van Dyke; John W Martyny; Margaret M Mroz; Lori J Silveira; Matt Strand; Donna L Cragle; William G Tankersley; Susan M Wells; Lee S Newman; Lisa A Maier
Journal:  Occup Environ Med       Date:  2011-04-02       Impact factor: 4.402

7.  Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada.

Authors:  Marcos Ribeiro; Leandro G Fritscher; Ahmed M Al-Musaed; Meyer S Balter; Victor Hoffstein; Bruce D Mazer; Lisa A Maier; Gary M Liss; Susan M Tarlo
Journal:  Lung       Date:  2011-03-13       Impact factor: 2.584

8.  The uses and adverse effects of beryllium on health.

Authors:  Ross G Cooper; Adrian P Harrison
Journal:  Indian J Occup Environ Med       Date:  2009-08

9.  Illness absences among beryllium sensitized workers.

Authors:  Janice P Watkins; Elizabeth D Ellis; David J Girardi; Donna L Cragle; Bonnie S Richter
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

10.  Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.

Authors:  Margaret M Mroz; Lisa A Maier; Matthew Strand; Lori Silviera; Lee S Newman
Journal:  Am J Ind Med       Date:  2009-10       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.